About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
LPTX - LEAP THERAPEUTICS| Previous Close | $1.62 | Open | |
| Volume | Market Cap | 98.44M | |
| Yield | Last Dividend |
| Three biotechs set terms in a hunt for $... | 03/22/21 |
| We have a slate of biotech IPO terms to report this morning. Design Therapeutics is applying a high valuation to the company. The preclinical biotech ... | |
| Leap Therapeutics Presents DKN-01 Clinic... | 03/22/21 |
| CAMBRIDGE, Mass., March 22, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and imm... | |
| Leap Therapeutics to Present at Upcoming... | 02/22/21 |
| CAMBRIDGE, Mass., Feb. 22, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immu... | |
| The Daily Biotech Pulse: DermTech Soars ... | 02/11/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X... | |
| Leap Therapeutics to Present at H.C. Wai... | 01/06/21 |
| CAMBRIDGE, Mass., Jan. 6, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immun... | |
| Leap Therapeutics to Participate at Pipe... | 11/23/20 |
| CAMBRIDGE, Mass., Nov. 23, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immu... | |
| Leap Therapeutics (NASDAQ:LPTX) Given a ... | 11/20/20 |
| Raymond James set a $2.50 target price on Leap Therapeutics (NASDAQ:LPTX) in a report released on Monday morning, BayStreet.CA reports. The firm curre... | |
| Leap Therapeutics Reports Third Quarter ... | 11/12/20 |
| CAMBRIDGE, Mass., Nov. 12, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immu... | |
| Leap Therapeutics to Present at Stifel 2... | 11/10/20 |
| CAMBRIDGE, Mass., Nov. 10, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immu... | |
| Leap Therapeutics Presents DKN-01 Monoth... | 11/09/20 |
| CAMBRIDGE, Mass., Nov. 9, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immun... | |
| The Week Ahead In Biotech: Supernus, San... | 11/08/20 |
| Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a change of gua... | |
| Leap Therapeutics to Present Esophagogas... | 10/15/20 |
| CAMBRIDGE, Mass., Oct. 15, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immu... | |
| Leap Therapeutics and BeiGene Announce F... | 09/21/20 |
| CAMBRIDGE, Mass. and BEIJING, Sept. 21, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targ... | |
| Leap Therapeutics to Present at H.C. Wai... | 09/09/20 |
| CAMBRIDGE, Mass., Sept. 9, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immu... | |
| Leap Therapeutics Reports Second Quarter... | 08/13/20 |
| CAMBRIDGE, Mass., Aug. 13, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immu... | |
| Leap Therapeutics Announces Closing of P... | 06/22/20 |
| CAMBRIDGE, Mass., June 22, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immu... | |
| Leap Therapeutics Announces Proposed Pub... | 06/17/20 |
| CAMBRIDGE, Mass., June 17, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immu... | |
| Leap Therapeutics Reports First Quarter ... | 05/14/20 |
| CAMBRIDGE, Mass., May 14, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immu... | |
| Leap Therapeutics to Present Updated Dat... | 04/23/20 |
| CAMBRIDGE, Mass., April 23, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and im... | |
| Leap Therapeutics to Present at Cowen 40... | 02/26/20 |
| CAMBRIDGE, Mass., Feb. 26, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and imm... | |
| The Daily Biotech Pulse: Heron Pain Drug... | 02/20/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) ... | |
| Leap Therapeutics to Present at 22nd Ann... | 02/04/20 |
| CAMBRIDGE, Mass., Feb. 4, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immu... | |
| NNVC, SLM, FCEL and TTPH among midday mo... | 01/23/20 |
| Gainers: Trans World Entertainment TWMC +260%. Co-Diagnostics CODX +89%. NanoViricides NNVC +55%. Kaleido BioSciences (NASDAQ:KLDO) +37%. Leap Therape... | |
| Leap's DKN-01 shows positive effect in e... | 01/23/20 |
| Updated results from a recently completed Phase 1/2 clinical trial, P102 (KEYNOTE-731), evaluating Leap Therapeutics' (NASDAQ:LPTX) DKN-01, combined w... | |
| Leap Therapeutics Presents Updated Data ... | 01/23/20 |
| CAMBRIDGE, Mass., Jan. 23, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX) today presented updated clinical data from its recently complet... | |
| Leap Therapeutics Announces Closing of P... | 01/07/20 |
| CAMBRIDGE, Mass., Jan. 7, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immu... | |
| Leap Therapeutics Surges on License Agre... | 01/06/20 |
| Leap Therapeutics (LPTX) signs agreement with China-based BieGene granting the latter rights to develop its pipeline candidate, DKN-01. It also signs ... | |
| Leap Therapeutics (NASDAQ:LPTX) Stock Pr... | 11/16/19 |
| Shares of Leap Therapeutics Inc (NASDAQ:LPTX) dropped 46.1% during mid-day trading on Thursday . The company traded as low as $0.57 and last traded at... | |
| The Daily Biotech Pulse: Amarin Gets Una... | 11/15/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) ... | |
| Strong Buy rating | 03/02/21 |
| Raymond James maintains Outperform rating and raises Price Target from $2.50 to $3.50 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Tech Trades | Tech Trades | 81.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
